Cargando…

Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy

INTRODUCTION: Triple negative breast cancer lacks estrogen, progesterone and epidermal growth factor receptors rendering it refractory to available targetedtherapies. TNBC is associated with central fibrosis and necrosis, both indicators of tumor hypoxia. Hypoxia inducible factor 1α is up-regulated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yehia, Lamis, Boulos, Fouad, Jabbour, Mark, Mahfoud, Ziyad, Fakhruddin, Najla, El-Sabban, Marwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457831/ https://www.ncbi.nlm.nih.gov/pubmed/26046764 http://dx.doi.org/10.1371/journal.pone.0129356

Ejemplares similares

Cx43 Expression Correlates with Breast Cancer Metastasis in MDA-MB-231 Cells In Vitro, In a Mouse Xenograft Model and in Human Breast Cancer Tissues
por: Kazan, Jalal M., et al.
Publicado: (2019)

Lymphoepithelioma-Like Carcinoma of the Breast: A Case Report Unveiling Several Clinical and Histopathological Challenges
por: Aridi, Tarek, et al.
Publicado: (2018)

Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer()
por: Ribatti, Domenico, et al.
Publicado: (2016)

Vaccine targeting HIF1A in triple negative breast cancer
por: Cecil, Denise, et al.
Publicado: (2014)

miRNA as Potential Biomarkers of Breast Cancer in the Lebanese Population and in Young Women: A Pilot Study
por: Nassar, Farah J., et al.
Publicado: (2014)

Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer
por: Wang, Maoli, et al.
Publicado: (2022)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
por: Leeha, Marisa, et al.
Publicado: (2023)

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
por: Chen, Xi, et al.
Publicado: (2012)

Triple-negative breast cancer molecular subtyping and treatment progress
por: Yin, Li, et al.
Publicado: (2020)

Molecular stratification within triple-negative breast cancer subtypes
por: Wang, Dong-Yu, et al.
Publicado: (2019)

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping
por: Yu, Xinjian, et al.
Publicado: (2022)

Future of Triple Negative Breast Cancer: Can Immunotherapy Treat This Deadly Subtype of Breast Cancer?
por: Salimi, Mona
Publicado: (2018)

Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2021)

Triple Negative Breast Cancer: An Analysis of the Subtypes and the Effects of Menopausal Status on Invasive Breast Cancer
por: Nishimura, Reiki, et al.
Publicado: (2022)

Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer compared to other subtypes of breast cancer
por: Bansal, Gaurav J, et al.
Publicado: (2016)

Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers
por: Di Mauro, Concetta, et al.
Publicado: (2017)

Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes
por: Chiavarina, Barbara, et al.
Publicado: (2014)

Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft
por: Bharti, Santosh K., et al.
Publicado: (2018)

Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo
por: Zibara, Kazem, et al.
Publicado: (2015)

Optical Redox Imaging Differentiates Triple-Negative Breast Cancer Subtypes
por: Jiang, Jinxia, et al.
Publicado: (2021)

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
por: Cserni, Gábor, et al.
Publicado: (2021)

XBP1 Promotes Triple Negative Breast Cancer By Controlling the HIF1 α Pathway
por: Chen, Xi, et al.
Publicado: (2014)

ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer
por: Fang, Wentong, et al.
Publicado: (2021)

HIF and COX-2 expression in triple negative breast cancer cells with hypoxia and 5-fluorouracil
por: Mori, Noriko, et al.
Publicado: (2020)

Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome
por: Brewer, Takae, et al.
Publicado: (2023)

Treatment outcome in patients with triple negative early stage breast cancers compared with other molecular subtypes
por: Kim, Ja Young, et al.
Publicado: (2012)

Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells
por: Chinchar, Edmund, et al.
Publicado: (2014)

Angiogenesis and Breast Cancer
por: Longatto Filho, Adhemar, et al.
Publicado: (2010)

Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer
por: Mastracci, Teresa L, et al.
Publicado: (2007)

Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?
por: Le Du, Fanny, et al.
Publicado: (2015)

Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity
por: Ding, Yuan Chun, et al.
Publicado: (2019)

Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
por: Giuli, M. V., et al.
Publicado: (2019)

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
por: Jézéquel, Pascal, et al.
Publicado: (2019)

Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
por: Hill, David P., et al.
Publicado: (2019)

Radiomics in Triple Negative Breast Cancer: New Horizons in an Aggressive Subtype of the Disease
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications
por: Asleh, Karama, et al.
Publicado: (2022)

Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer
por: Pu, Shengyu, et al.
Publicado: (2022)

Rare subtypes of triple negative breast cancer: Current understanding and future directions
por: Thomas, Alexandra, et al.
Publicado: (2023)

Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer
por: Tong, Ling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8urhaaon4p23f20b67v52f59df